Expedited partner therapy for adolescents diagnosed with gonorrhea or chlamydia: a review and commentary.
Management of sex partners is a cornerstone of sexually transmitted infection control in the United States. Face-to-face investigation and notification of exposure of sex partners by public health professionals seems to be the most effective method of ensuring appropriate partner management. However, resources rarely permit such intensive partner management for gonorrhea and chlamydial infection. Alternatives to public health-assisted notification and referral include expedited partner therapy, in which partners are treated before evaluation, most typically through patient-delivered therapy. Results from trials have shown generally favorable biomedical and behavioral outcomes. This article discusses the evidence for expedited partner therapy and its associated liability, confidentiality, financial, and administrative issues relating to adolescent patients and their health care providers.
Hogben
Matthew
M
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. yzh5@cdc.gov
Burstein
Gale R
GR
D000293:Adolescent; D002690:Chlamydia Infections / Q000188:drug therapy* / Q000517:prevention & control*; D016358:Contact Tracing / Q000379:methods; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D016365:Liability, Legal; D008297:Male; D033242:Minors / Q000331:legislation & jurisprudence; D010349:Patient Compliance; D012747:Sexual Partners